Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Sorilux® (calcipotriene) – Expanded indication
May 6, 2019 - The FDA approved Mayne Pharma’s Sorilux (calcipotriene) foam, for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older.
